0000950103-22-012374.txt : 20220713
0000950103-22-012374.hdr.sgml : 20220713
20220713213140
ACCESSION NUMBER: 0000950103-22-012374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220711
FILED AS OF DATE: 20220713
DATE AS OF CHANGE: 20220713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McKenzie Libbie Parker
CENTRAL INDEX KEY: 0001936222
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40560
FILM NUMBER: 221082118
MAIL ADDRESS:
STREET 1: C/O PROKIDNEY CORP.
STREET 2: 3929 WESTPOINT BLVD., SUITE G
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROKIDNEY CORP.
CENTRAL INDEX KEY: 0001850270
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 981586514
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3929 WESTPOINT BLVD.
STREET 2: SUITE G
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27103
BUSINESS PHONE: 336-999-7029
MAIL ADDRESS:
STREET 1: 3929 WESTPOINT BLVD.
STREET 2: SUITE G
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27103
FORMER COMPANY:
FORMER CONFORMED NAME: Social Capital Suvretta Holdings Corp. III
DATE OF NAME CHANGE: 20210310
4
1
dp177032_4-mckenzie.xml
FORM 4
X0306
4
2022-07-11
0
0001850270
PROKIDNEY CORP.
PROK
0001936222
McKenzie Libbie Parker
C/O PROKIDNEY CORP.
2000 FRONTIS PLAZA BOULEVARD, SUITE 250
WINSTON-SALEM
NC
27103
0
1
0
0
Chief Medical Officer
Class B Ordinary Shares
2022-07-11
4
A
0
327713
0
A
Class A Ordinary Shares
327713
327713
D
Common Units in ProKidney LP
2022-07-11
4
A
0
327713
0
A
Class A Ordinary Shares
327713
327713
D
Each Class B Ordinary Share has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the Securities and Exchange Commission on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP ("ProKidney") (a "Common Unit"), for a Class A Ordinary Share on a one-for-one basis.
These 327,713 Restricted Stock Rights in respect of Class B Ordinary Shares ("Class B PMEL RSRs") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the "Business Combination Agreement") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through April 18, 2026, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire.
Each Common Unit may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, be exchanged, together with the paired Class B Ordinary Share, into a Class A Ordinary Share on a one-for-one basis.
These 327,713 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units ("PMEL RCUs") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through April 18, 2026. The Common Units and the PMEL RCUs do not expire.
/s/ Todd Girolamo as Attorney-in-Fact for Libbie P McKenzie
2022-07-13